Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Int J Infect Dis. 2020 Jun 17;98:130–137. doi: 10.1016/j.ijid.2020.06.046

Table 3.

Prevalence of sexually transmitted infections by sex. age and HIV status

Age Group Males Females
HIV negative HIV Positive P value HIV Negative HIV Positive P value
% (95% CI) % (95% CI) % (95% CI) % (95% CI)
Herpes simplex virus type 2 antibodies
 15–19 7.6 5.1–10.1 24.1 7.2–41 0.0051 20.4 16.8–24.0 58.2 46.2–70.2 <0.0001
 20–24 17.3 13.5–21.0 62.3 48.9–75.7 <0.0001 45.2 40.4–50.0 87.8 83.5–92.1 <0.0001
 25–29 38.2 31.9–44.5 86.6 79.9–93.4 <0.0001 57.4 50.5–64.3 93.3 90.7–96.0 <0.0001
 30–34 50.5 42.3–58.8 85.7 78.8–92.6 <0.0001 63.0 55.6–70.5 97.4 95.9–98.9 <0.0001
 35–39 51.4 41.5–61.3 93.5 88.4–98.6 <0.0001 67.8 59.2–76.4 95.9 93.3–98.6 <0.0001
 40–44 70.2 60.0–80.3 93.7 89.4–98.1 <0.0001 78.9 71.0–86.9 98.4 96.5–100 <0.0001
 45–49 64.9 55.3–74.6 99.2 98.1–100 <0.0001 88.4 84.4–92.3 98.3 96.8–99.8 <0.0001
Total 30.3 27.9–32.8 86.3 83.2–89.5 <0.0001 49.4 47.0–51.9 93.3 92.0–94.5 <0.0001
Syphilis antibodiesa
 15–19 0.8 0.1–1.4 1.6 0–4.7 0.5012 0.7 0.2–1.1 8.4 1–15.9 <0.0001
 20–24 2.3 0.3–4.2 8.0 1.8–14.2 0.019 3.5 1.7–5.2 8.5 5.5–11.4 0.0013
 25–29 1.8 0–3.9 4.4 0–9.0 0.2415 2.1 0.3–3.9 5.1 2.4–7.8 0.0753
 30–34 2.9 0–6.3 2.3 0.2–4.5 0.7531 1.4 0–2.8 3.5 1.4–5.5 0.0938
 35–39 4.4 0–8.9 3.3 0.5–6.1 0.6684 1.5 0–3.1 1.7 0.5–3.0 0.8095
 40–44 2.1 0–4.3 3.6 0.5–6.7 0.4451 2.6 0–5.7 3.8 1.8–5.8 0.5756
 45–49 2.8 0.6–4.9 2.3 0–5.5 0.8142 3.3 1.1–5.5 0.6 0–1.4 0.0132
Total 2.1 1.2–2.9 3.5 2.2–4.9 0.0659 2.1 1.4–2.7 4.2 3.3–5.1 <0.0001
Neisseria gonorrhoeae
 15–19 0.8 0.2–1.5 3.5 0–8.3 0.0578 3.1 1.6–4.6 12.7 5.3–20.1 0.0002
 20–24 2.6 1–4.3 5.4 0–11.0 0.2451 4.0 2.2–5.8 11.9 7.9–15.8 0.0001
 25–29 1.7 0.2–3.1 5.7 0.7–10.8 0.0468 3.5 0.8–6.2 5.2 2.6–7.8 0.3831
 30–34 3.4 0–7.0 1.4 0.1–2.8 0.2143 0.5 0–1.0 4.6 2.2–6.9 <0.0001
 35–39 0.4 0–1.0 0.5 0–1.6 0.808 0.6 0–1.4 1.9 0.8–3.0 0.0821
 40–44 1.3 0–3.3 0.2 0–0.6 0.0965 1.6 0–4.4 2.6 0.5–4.6 0.6249
 45–49 - - - - 0.6 0–1.3 1.6 0.2–3.1 0.1638
Total 1.7 0.9–2.5 2.0 0.9–3.1 0.5706 2.6 2.0–3.3 5.1 4.1–6.1 <0.0001
Chlamydia trachomatis
 15–19 4.6 2.6–6.5 - - 14 11.2–16.8 15.3 6.7–23.9 0.7724
 20–24 8.7 6.2–11.2 7.9 0–16.6 0.8772 16.5 13.1–19.9 13.9 9.7–18.0 0.3631
 25–29 6.4 3.9–8.9 10.6 4.4–16.7 0.1561 7.7 4.8–10.6 11.8 8.1–15.5 0.0715
 30–34 8.3 3.2–13.4 1.8 0.4–3.3 0.0006 3.5 1.1–5.9 6.1 3.9–8.4 0.1527
 35–39 1.9 0.4–3.5 0.8 0–1.7 0.2101 2.6 1.1–4.2 5.5 2.6–8.4 0.0393
 40–44 - - 1.9 0–3.8 - 2.3 0.1–4.4 2.8 0.7–5.0 0.7281
 45–49 - - 1.2 0–3.5 - 0.7 0–1.5 1.3 0–2.7 0.4375
Total 5.7 4.5–6.8 3.5 2.0–5.0 0.048 9.8 8.6–11.1 7.9 6.5–9.2 0.0371
Trichomonas vaginalis
 15–19 0.5 0–1.1 1.6 0–4.7 0.289 10.9 8.3–13.5 15.1 7.7–22.4 0.2662
 20–24 1.7 0.4–2.9 3.5 0–7.4 0.2603 10.0 7.3–12.7 18.5 14.3–22.7 0.0001
 25–29 1.4 0.4–2.4 8.2 2.4–13.9 0.0001 7.1 4.6–9.5 19.3 14.8–23.8 <0.0001
 30–34 4.2 0.4–7.9 4.5 0.7–8.2 0.9078 6.5 3.3–9.7 13.3 9.7–16.9 0.0051
 35–39 5.0 1.8–8.2 8.1 2.2–14.0 0.3344 11.0 6.2–15.7 20.5 15.3–25.7 0.0107
 40–44 10.2 5–15.3 12.0 6.2–17.7 0.6566 11.1 5.7–16.6 18.6 13.6–23.5 0.0467
 45–49 6.7 1.4–12 6.1 2–10.2 0.8596 17.6 12.1–23.1 22.0 16.4–27.7 0.2632
Total 2.6 1.8–3.3 7.3 5.1–9.4 <0.0001 10.3 8.9–11.8 18.1 16.0–20.2 <0.0001
Mycoplasma genitalium
 15–19 1.7 0.6–2.7 6.6 0–14.7 0.0375 4.8 2.8–6.8 9.5 3.6–15.4 0.0747
 20–24 2.7 1.4–4 7.3 1.4–13.3 0.0353 6.6 4.3–9 12.0 8.2–15.9 0.0069
 25–29 9.1 5.5–12.6 9.7 5–14.4 0.8208 5.3 2.8–7.8 8.7 5.4–11.9 0.1083
 30–34 7.2 3–11.4 14.5 8.4–20.6 0.0544 3.1 0.6–5.6 3.8 1.8–5.9 0.6673
 35–39 5.8 1.8–9.9 10.4 4.9–15.9 0.2126 1.7 0–3.6 6.4 3.3–9.5 0.0172
 40–44 3.3 0–7.2 5.2 2.5–7.9 0.4453 1.4 0–3.2 2.8 1.2–4.5 0.3104
 45–49 2.6 0–6.6 2.8 0.2–5.3 0.9365 0.9 0–2.4 1.3 0–2.7 0.7629
Total 4.4 3.3–5.5 9.2 7.2–11.2 <0.0001 4.4 3.3–5.4 6.4 5.2–7.5 0.0086
a=

qualitative detection of antibodies suggestive of a past or current infection